Skip to main content

Table 3 Crude and adjusted hazard ratios (HR) of death in all ventilated patients (derived using Cox proportional hazard regression models)

From: Effect of end-stage renal disease on long-term survival after a first-ever mechanical ventilation: a population-based study

Cohort

Crude HR (95 % CI)

Adjusted HR (95 % CI)

ESRD

 Yes

1.47 (1.36–1.57)

1.43 (1.33–1.54)

 No

1.00

1.00

Age (years)

 0–50

1.00

1.00

 50–64

1.51 (1.37–1.66)

1.50 (1.36–1.65)

 ≧65

2.18 (1.99–2.38)

2.03 (1.85–2.23)

Sex

 Female

1.00 (0.95–1.05)

0.94 (0.89–0.99)

 Male

1.00

1.00

Comorbidity

 Diabetes

1.30 (1.24–1.36)

1.18 (1.13–1.25)

 Hypertension

1.10 (1.05–1.16)

0.99 (0.94–1.05)

 Coronary artery disease

1.00 (0.95–1.06)

0.93 (0.88–1.01)

 Liver cirrhosis

1.90 (1.77–2.04)

1.61 (1.50–1.74)

 COPD

1.20 (1.12–1.28)

1.01 (0.95–1.08)

 Cancer

1.33 (1.24–1.41)

1.49 (1.39–1.59)

 Stroke

1.28 (1.21–1.34)

1.26 (1.19–1.33)

 CHF

1.24 (1.17–1.32)

1.17 (1.10–1.25)

Department to which admitted

 Surgery

0.50 (0.47–0.53)

0.64 (0.60–0.68)

 Medical

1.00

1.00

Number of organ failures (other than lungs and kidneys)

 0

1.00

1.00

 1

2.14 (2.03–2.26)

1.85 (1.75–1.95)

 ≥2

2.79 (2.41–3.23)

2.46 (2.12–2.86)

Ventilator duration (days) (continuous)

1.00 (1.00–1.00)

1.00 (1.00–1.00)

ICU stay (days) (continuous)

1.00 (1.00–1.00)

1.00 (1.00–1.01)

Hospital stay (days) (continuous)

0.99 (0.99–1.00)

1.00 (0.99–1.00)

  1. HR hazard ratio, CI confidence interval, ESRD end-stage renal disease, COPD chronic obstructive airway disease, CHF congestive heart disease, ICU intensive care unit